Skip to content
Winfred
Sign up
Back to Investors
Parkwalk Advisors

Parkwalk Advisors

Venture Capital
Follow

Parkwalk Advisors is a London-based fund management firm managing investment-driven venture capital funds.

Website

Portfolio

37

companies

AUM

£500M

under management

Investment by month

By category

  • Quantum Computing£160M
  • BioTech£76.4M
  • AI/ML£74.3M
  • Uncategorised£47.7M
  • AgriTech£41.3M
  • Other£139M

By location

  • London£285M
  • Oxford£124M
  • Cambridge£115M
  • United Kingdom£6.7M
  • Leeds£3.5M
  • Other£3.5M

Portfolio companies

A

Arkivum

Arkivum provides long-term data safeguarding and data usability solutions.

Bitfount

Bitfount

Federated AI platform enabling secure clinical research collaboration without data sharing.

Brainomix

Brainomix

Artificial intelligence software for medical imaging diagnostics.

BE

Bramble Energy

Bramble Energy develops printed circuit board fuel cell technology for hydrogen power.

CG

Cambridge GaN Devices

Developer of power semiconductor devices using Gallium-Nitride on Silicon technology.

Ceryx Medical

Ceryx Medical

Ceryx Medical develops next-generation bioelectronic therapies for heart failure.

View all 37 companies
CN

Charco Neurotech

Charco Neurotech develops medical devices to help manage movement symptoms associated with Parkinson disease.

Congenica

Congenica

Congenica provides software that accelerates genomic data analysis for personalised medicine.

Diffblue

Diffblue

Diffblue provides autonomous generative artificial intelligence software that automates unit test generation for developers.

Enhanc3D Genomics

Enhanc3D Genomics

Enhanc3D Genomics develops functional genomics platforms that map the human three dimensional genome to transform therapeutic development.

FA

Fluidic Analytics

Fluidic Analytics builds devices to characterise proteins.

F

Flusso

Flusso develops miniaturised flow sensors for consumer and industrial applications.

G

GeoSpock

GeoSpock develops high performance database technology for large scale spatial and temporal data analytics.

GripAble

GripAble

GripAble provides digital rehabilitation programmes for neurological and musculoskeletal conditions.

Legislate

Legislate

Legislate provides a knowledge graph platform that allows businesses to query and compare contract terms.

LT

Legislate Technologies

Legislate Technologies provides a software platform for small businesses and landlords to create and manage contracts.

Mind Foundry

Mind Foundry

Mind Foundry develops artificial intelligence platforms designed to help organisations make better operational decisions.

Mint Neurotechnologies

Mint Neurotechnologies

Semiconductor developer creating scalable and low-power neural implants.

MT

MoA Technology

MoA Technology develops next-generation herbicides to combat global weed resistance.

Mogrify

Mogrify

Mogrify develops in vivo reprogramming therapies to transform patient outcomes in degenerative diseases.

Nozzle.ai

Nozzle.ai

An eCommerce and advertising optimisation platform for Amazon.

O

OSSTEC

Developing smart bone implants for younger knee replacement patients.

O

OW

OW combines artificial intelligence with proprietary hardware to print smells.

OS

OW Smell Made Digital

OW Smell Made Digital develops digital scent technology to enhance sleep and immersive experiences.

O

Opsydia

Opsydia produces sub-surface gemstone laser inscription technology for diamond identification.

Oxford Endovascular

Oxford Endovascular

Oxford Endovascular develops origami-inspired medical devices for brain aneurysm treatment.

Paragraf

Paragraf

Paragraf manufactures scalable graphene-based electronic devices.

P

PervasID

PervasID develops radio frequency identification technology for asset tracking.

Phasecraft

Phasecraft

Phasecraft develops high performance algorithms to unlock the practical capabilities of quantum computers.

PhoreMost

PhoreMost

PhoreMost develops targeted therapies for cancer and age related conditions.

Psyomics

Psyomics

Psyomics develops artificial intelligence software to improve mental health assessment and diagnosis.

Qkine

Qkine

Qkine manufactures specialist bioactive proteins for stem cell and regenerative medicine applications.

QM

Quantum Motion

Quantum Motion builds silicon transistor-based quantum computers designed for standard data-centre racks.

SE

Spectral Edge

Spectral Edge builds image fusion and colour perception technologies for electronic devices.

T

Trismik

Trismik builds adaptive evaluation infrastructure for artificial intelligence systems.

Y

YASA

YASA manufactures axial flux electric motors and controllers for electric vehicles.

adsilico

adsilico

Adsilico builds virtual patient populations for medical device testing.

Team

John Pearson

John Pearson

Chief Investment Officer

John serves as Chief Investment Officer at Parkwalk Advisors, following earlier experience as a partner at Adelphi Capital. He holds board experience from non-executive director roles at several technology and engineering companies.

Moray Wright

Moray Wright

COO

Moray leads Parkwalk Advisors as chief executive officer and chairs PervasID. He also holds directorships at Oxa and Cambridge Touch Technologies.

LinkedIn
LC

Lulu Carter

Account Manager

Claire Pardo

Claire Pardo

Claire brings legal experience from positions at Parkwalk Advisors and Freshfields Bruckhaus Deringer. She currently serves as general counsel at a sports data analytics consultancy.

LinkedIn

Recent investments

Series C
£118M

Quantum Motion secures £117.5m Series C investment co-led by DCVC and Kembara to advance silicon quantum computing.

Quantum ComputingHardware

The funding round was co-led by DCVC and Kembara with participation from the British Business Bank and Firgun.

"Today's announcement reflects the strength of the team we have built and the progress they have delivered. Quantum computing will only achieve its full potential if it can be built on a platform that scales, and we believe silicon is the strongest route to achieving that. We are pleased to be joined by investors who share our vision and understand what it takes to build a foundational company in this field."
— James Palles-Dimmock, CEO
QM
Quantum Motion— London, UK Follow
DCVC
K
British Business Bank
DCVC + 8 others
Pre-Seed
£2.2M

Trismik secures £2.2m in pre seed funding led by Twinpath Ventures to launch its AI evaluation platform.

AI/MLSaaSEnterprise Software

The pre seed round was led by Twinpath Ventures with participation from a syndicate of institutional and angel investors.

"If we want to trust AI, our methods have to be as rigorous as our ideas. Benchmark saturation is creating problems in every domain, from general knowledge, to reasoning, math, and coding. Scientists, researchers and technical teams face mounting pressure as evaluation is exploding in importance and has become essential for tying AI to trust. We need an evaluation framework that scales and can support this."
— Nigel Collier, Chief Scientific Officer
T
Trismik— Cambridge, UK Follow
T
Cambridge Enterprise
Parkwalk Advisors
Twinpath + 5 others
Series B
£25.3M

Phasecraft raises £25.3m Series B funding from Plural, Playground Global, and Novo Holdings to advance quantum algorithms.

Phasecraft

The round was co-led by Plural, Playground Global, and Novo Holdings.

"We’re actively creating quantum advantage at Phasecraft. Our algorithms are delivering meaningful results now, whether it’s simulating the physics of complex materials or optimizing the structure of a large energy network, whilst our partnerships with the world’s top quantum hardware providers increase the impact our algorithms will have for commercial applications. We’re delighted to have the backing of our visionary investors such as Plural, Playground Global, and Novo Holdings, to support us on the mission to bring quantum advantage to the world faster."
— Ashley Montanaro, CEO
Phasecraft
Phasecraft— London, UK Follow
Plural
PG
Novo Holdings
Plural + 5 others
Seed
£11.0M

Ceryx Medical secures £11m from BGF and other backers to advance its permanent bioelectronic pacemaker.

Ceryx Medical
MedTech

The funding round was supported by BGF, Parkwalk Advisors, DBW, and BBI to drive clinical and product development.

"This investment is a strong endorsement of our team, technology, and vision. The early clinical data from our temporary device has given us real momentum, and with this funding, we’re excited to advance our permanent pacing platform, an innovation that could redefine how heart failure is treated."
— Stuart Plant, CEO
Ceryx Medical
Ceryx Medical— London, UK Follow
BGF
Parkwalk Advisors
D
BGF + 3 others